Rx Safes, Inc. (OTCQB: RXSF), a healthcare technology company and developer of autonomous fingerprint healthcare security products, today announced the availability of its portable electronic health record (EHR) device called the Rx SafeEHR™. The Rx SafeEHR™ is a HIPAA compliant, fingerprint-secured portable storage device that allows healthcare providers the ability to securely store and exchange patient health records with other medical professionals at the authority of the patient.
The Rx SafeEHR™ addresses the growing concern over unauthorized access to digital health records. It allows for the secure storage and transmission of sensitive patient information between healthcare systems, providers and patients. With a variety of storage sizes available, all types of patient data including high resolution patient scans and X-rays can be downloaded onto the Rx SafeEHR™ device and transported by the patient for review and assessment by their physicians.
With biometric security, the Rx SafeEHR™ allows patients with multiple healthcare providers the ability to maintain accurate health records and share these records securely between providers. The information on the device can only be retrieved by the patient or persons authorized by the patient, via the company’s biometric authentication platform and then downloaded directly to another healthcare professional’s computer. The requirement of a patient’s fingerprint assures both the patient and the physician that there is proper authorization to access the health record, and this complies with the mandates of the Health Information Privacy and Portability Act (HIPPA).
“There is a huge data gap between healthcare services such as emergency room visits and the follow up care that a patient receives with specialists or family physicians. The Rx SafeEHR™ has been designed to directly address these issues and allow patients the ability to maintain a secure and accurate mobile health record that can be shared only upon their authorization,” commented Lorraine Yarde, Rx Safes’ Chief Executive Officer.
Rx SafeEHR™ is a professional product intended to be issued by healthcare systems to their patients and can be integrated within any Healthcare IT software environment. This is the company’s first Healthcare IT product and the device is currently in its testing phase. The Company expects to release the Rx SafeEHR™ in 2016 as part of a new initiative targeting the largest healthcare systems in the country.
About Rx Safes, Inc.
Rx Safes is medical device and healthcare technology company, and is an emerging leader in the personal and professional healthcare drug security market. Our products incorporate proprietary patented fingerprint technology to provide drug security solutions for use in homes and healthcare facilities. Prescription drug misuse, skyrocketing insurance and pharmaceutical treatment costs and increased regulatory pressures create an unfortunate, yet necessary opportunity for Rx Safes to expand our reach and offerings in this growing market, valued at over $50 billion annually. Annual spending on healthcare technology products exceeds $34.5 billion. In addition, the market is being driven by ongoing Government support for successful drug abuse prevention initiatives, with a financial commitment of $25.4 billion in 2015 alone. For more information, please visit www.rxdrugsafe.com.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management’s current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company’s business strategy. The Company’s actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the Company’s ability to implement its long range business plan for various applications of its technology; the Company’s ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company’s technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company’s reports filed with the Securities and Exchange Commission.
Investor Relations Contact:
Like us on Facebook at https://www.facebook.com/rxsafes
Follow us on Twitter at https://twitter.com/RxDrugSAFE